Home About Us Philosophy Technology Overview Current Product Focus Future Product Focus Corporate Partners Management Contact Us
During the next 12 to 24 months Braasch will focus on specific new vaccine products that address problems in: Human Health Myocardial Infarction Treatment. Diabetes Applications. Specific Neurological Treatments for IGF-1 responsive disorders. Copyright © 2010 Braasch Biotech LLC. All rights reserved. Webmaster
Human Health
Copyright © 2010 Braasch Biotech LLC. All rights reserved. Webmaster
News and Releases August 31, 2009 New Braasch Biotech Vaccine Technology Provides Growth Hormone and IGF-1 Treatments without the use of drugs New Braasch Biotech Vaccine Technology Promises Greater Livestock Productivity and Obesity Treatment without drugs
New Braasch Biotech Vaccine Technology Promises Greater Livestock Productivity and Obesity Treatment without drugs